Oral plasmalogens have anti-inflammatory and anti-amyloidogenic properties,29 can activate microglia and improve LPS-induced memory loss via increased gene expression of brain-derived neurotrophic factor (BDNF) in a mouse model of AD.30 This evidence concerns the gene BDNF and Alzheimer disease.